Abstract
Background Current clinical classifications of chronic rhinosinusitis (CRS) have weak prognostic utility regarding treatment outcomes. Simplified discriminant analysis based on unsupervised clustering has identified novel phenotypic subgroups of CRS, but prognostic utility is unknown. Objective We sought to determine whether discriminant analysis allows prognostication in patients choosing surgery versus continued medical management. Methods A multi-institutional prospective study of patients with CRS in whom initial medical therapy failed who then self-selected continued medical management or surgical treatment was used to separate patients into 5 clusters based on a previously described discriminant analysis using total Sino-Nasal Outcome Test-22 (SNOT-22) score, age, and missed productivity. Patients completed the SNOT-22 at baseline and for 18 months of follow-up. Baseline demographic and objective measures included olfactory testing, computed tomography, and endoscopy scoring. SNOT-22 outcomes for surgical versus continued medical treatment were compared across clusters. Results Data were available on 690 patients. Baseline differences in demographics, comorbidities, objective disease measures, and patient-reported outcomes were similar to previous clustering reports. Three of 5 clusters identified by means of discriminant analysis had improved SNOT-22 outcomes with surgical intervention when compared with continued medical management (surgery was a mean of 21.2 points better across these 3 clusters at 6 months, P <.05). These differences were sustained at 18 months of follow-up. Two of 5 clusters had similar outcomes when comparing surgery with continued medical management. Conclusion A simplified discriminant analysis based on 3 common clinical variables is able to cluster patients and provide prognostic information regarding surgical treatment versus continued medical management in patients with CRS.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1054-1062 |
| Number of pages | 9 |
| Journal | Journal of Allergy and Clinical Immunology |
| Volume | 137 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 1 2016 |
Funding
Z.M.S. and T.L.S. were supported for this investigation by a grant from the National Institute on Deafness and Other Communication Disorders (NIDCD), one of the National Institutes of Health, Bethesda, Maryland (R01 DC005805; PI/PD: T.L.S.). Public clinical trial registration (http://www.clinicaltrials.gov) was #NCT01332136. Z.M.S. was also supported for this investigation by another grant from the NIDCD (R03 DC013651-01). T.L.S. is a consultant for IntersectENT, which is not associated with this manuscript. Z.M.S. is a consultant for Olympus, which is not affiliated with this manuscript. R.J.S. is supported by grants from OptiNose and IntersectENT, neither of which are associated with this manuscript. R.J.S. is also a consultant for Olympus and Arrinex, which are not affiliated with this study. Z.M.S. and T.L.S. were supported for this investigation by a grant from the National Institute on Deafness and Other Communication Disorders (NIDCD), one of the National Institutes of Health , Bethesda, Maryland ( R01 DC005805 ; PI/PD: T.L.S.). Public clinical trial registration ( http://www.clinicaltrials.gov ) was # NCT01332136 . Z.M.S. was also supported for this investigation by another grant from the NIDCD ( R03 DC013651-01 ). T.L.S. is a consultant for IntersectENT, which is not associated with this manuscript. Z.M.S. is a consultant for Olympus, which is not affiliated with this manuscript. R.J.S. is supported by grants from OptiNose and IntersectENT, neither of which are associated with this manuscript. R.J.S. is also a consultant for Olympus and Arrinex, which are not affiliated with this study.
| Funders | Funder number |
|---|---|
| OptiNose | |
| Author National Institutes of Health National Institutes of Health National Institutes of Health National Institutes of Health The Bev Hartig Huntington's Disease Foundation National Institutes of Health | 01332136, R03 DC013651-01, UL1TR001450 |
| National Institute on Deafness and Other Communication Disorders R01DC012546 Xue Zhong Liu National Institute on Deafness and Other Communication Disorders R01DC012115 Xue Zhong Liu National Institute on Deafness and Other Communication Disorders R01DC014427 Ulrich Müller Peter G Barr-Gillespie National Institute on Deafnessand Other Communication Disorders R01DC005965 Ulrich Müller National Institute on Deafness and Other Communication Disorders | R01DC005805 |
| Olympus ACMI |
Keywords
- Chronic rhinosinusitis
- cluster
- outcomes
- prediction
- quality of life
- sinusitis
- treatment
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Fingerprint
Dive into the research topics of 'Cluster analysis and prediction of treatment outcomes for chronic rhinosinusitis'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS